Table 1. Baseline characteristics of the population.
All countries together1 |
No skin cancer (N=560) |
Squamous-cell carcinoma (with or without BCC) (N=224) |
Basal-cell carcinoma (with no SCC) (N=131) |
||
---|---|---|---|---|---|
Number male | |||||
N (%) | 384 (68.6) | 171 (76.3) | P=0.031 | 96 (73.3) | P=0.292 |
Age (years) | |||||
Mean (SD) | 52.4 (12.0) | 59.8 (9.2) | P<0.001 | 56.5 (10.6) | P<0.001 |
Min–max | 15.7–77.9 | 34.1–80.9 | 26.9–77.6 | ||
Time since Tx (years) | |||||
Mean (SD) | 11.9 (7.3) | 15.8 (7.6) | P<0.001 | 12.3 (7.0) | P=0.559 |
Min–max | 0.2–35.7 | 1.8–36.8 | 1.3–37.0 |
BCC, basal-cell carcinoma; SCC, squamous-cell carcinoma; SD, standard deviation; Tx, transplantation.
The data for the five countries are provided separately in >Table S1.